Paper17879211
Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
Rysz J and 7 others. J Nephrol, 2007. Cited by 78 papers, by iCite.
Cite this record
ConductScience Library. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy. Papers, record 17879211. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17879211
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Nephropathies | Major topic |
| Matrix Metalloproteinase 2 | Major topic |
| Matrix Metalloproteinase 9 | Major topic |
| Tissue Inhibitor of Metalloproteinase-1 | Major topic |
| Tissue Inhibitor of Metalloproteinase-2 | Major topic |
| Aged | |
| Diabetes Mellitus, Type 2 | |
| Female | |
| Humans | |
| Kidney Failure, Chronic | |
| Male | |
| Middle Aged | |
| Tumor Necrosis Factor-alpha |
Source PubMed
Cited by56
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41898171 | Morphometry and Immunoexpression of Metalloproteinase 2 and Its Inhibitor in the Fibrotic and Non-Fibrotic Grafted Kidney-Digital Analysis. | Biomedicines | 2026 | https://conductscience.org/library/papers/41898171 | PubMed |
| 40347331 | Zymography: Unveiling Matrix Metalloproteinase Dynamics. | Methods Mol Biol | 2025 | https://conductscience.org/library/papers/40347331 | PubMed |
| 39653743 | Dysregulation of MMP2-dependent TGF-ß2 activation impairs fibrous cap formation in type 2 diabetes-associated atherosclerosis. | Nat Commun | 2024 | https://conductscience.org/library/papers/39653743 | PubMed |
| 39361724 | Matrix metalloproteinases in kidney homeostasis and diseases: an update. | Am J Physiol Renal Physiol | 2024 | https://conductscience.org/library/papers/39361724 | PubMed |
| 39027501 | Bioflavonoid combination attenuates diabetes-induced nephropathy in rats via modulation of MMP-9/TIMP-1, TGF-β, and GLUT-4-associated pathways. | Heliyon | 2024 | https://conductscience.org/library/papers/39027501 | PubMed |
| 39001241 | Tissue Inhibitor of Metalloproteinases-2 (TIMP-2) as a Prognostic Biomarker in Acute Kidney Injury: A Narrative Review. | Diagnostics (Basel) | 2024 | https://conductscience.org/library/papers/39001241 | PubMed |
| 38610612 | The Possible Effect of β-Blocker Use on the Circulating MMP-2/TIMP-2 System in Patients with Chronic Kidney Disease on Conservative Treatment. | J Clin Med | 2024 | https://conductscience.org/library/papers/38610612 | PubMed |
| 37931406 | Matrix metalloproteinase-induced cervical extracellular matrix remodelling in pregnancy and cervical cancer. | Reprod Fertil | 2022 | https://conductscience.org/library/papers/37931406 | PubMed |
| 37446346 | Extracellular Matrix Expression in Human Pancreatic Fat Cells of Patients with Normal Glucose Regulation, Prediabetes and Type 2 Diabetes. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37446346 | PubMed |
| 37445827 | Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Metabolism: Insights into Health and Disease. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445827 | PubMed |
| 37237955 | Diabetic Nephropathy and Gaseous Modulators. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37237955 | PubMed |
| 36158067 | Pioglitazone in diabetic kidney disease: forgotten but not gone. | Arch Med Sci Atheroscler Dis | 2022 | https://conductscience.org/library/papers/36158067 | PubMed |
| 36013295 | Endotyping of Cholesteatoma: Which Molecular Biomarkers? A Systematic Review. | J Pers Med | 2022 | https://conductscience.org/library/papers/36013295 | PubMed |
| 34373703 | Ellagic acid inhibits high glucose-induced injury in rat mesangial cells via the PI3K/Akt/FOXO3a signaling pathway. | Exp Ther Med | 2021 | https://conductscience.org/library/papers/34373703 | PubMed |
| 34222087 | Association of dietary intake, medication and anthropometric indices with serum levels of advanced glycation end products, caspase-3, and matrix metalloproteinase-9 in diabetic patients. | J Diabetes Metab Disord | 2021 | https://conductscience.org/library/papers/34222087 | PubMed |
| 33842514 | Glomerular Endothelial Cell Crosstalk With Podocytes in Diabetic Kidney Disease. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/33842514 | PubMed |
| 33547417 | Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. | Nat Rev Nephrol | 2021 | https://conductscience.org/library/papers/33547417 | PubMed |
| 32046355 | Matrix Metalloproteinases in Diabetic Kidney Disease. | J Clin Med | 2020 | https://conductscience.org/library/papers/32046355 | PubMed |
| 31966810 | Hyperoside inhibited the migration and invasion of lung cancer cells through the upregulation of PI3K/AKT and p38 MAPK pathways. | Int J Clin Exp Pathol | 2017 | https://conductscience.org/library/papers/31966810 | PubMed |
| 31949240 | A Boolean Model of Microvascular Rarefaction to Predict Treatment Outcomes in Renal Disease. | Sci Rep | 2020 | https://conductscience.org/library/papers/31949240 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| TIMP1 | 7076 | PubTator's text mining | https://conductscience.org/library/genes/7076 | NCBI Gene |
| TIMP2 | 7077 | PubTator's text mining | https://conductscience.org/library/genes/7077 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17879211
GET https://conductscience.org/api/papers/v1/17879211/cited_by?page=2